21 Jul Silvia Alessi-Severini
Bio
Dr. Silvia Alessi-Severini is a Professor in the College of Pharmacy at the University of Manitoba and an Adjunct Scientist of the Manitoba Centre for Health Policy). A pharmacist by training, she obtained her PhD from the University of Alberta in 1993. Dr. Alessi-Severini teaches Toxicology in the PharmD program and Pharmacoepidemiology in the graduate program. Under her leadership the College of Pharmacy has implemented a Concentration in Pharmacoepidemiology within the Master and PhD programs. Her research focus is on the use and safety of psychotropic medications particularly in children and older adults; other interests include the study of the delivery of health care to refugees and asylum seekers in Canada, as well as the utilization of direct-acting antivirals for the treatment of hepatitis C. She is serving on various University of Manitoba committees including Senate and the Rady Faculty of Health Sciences Faculty Executive Council. Dr. Alessi-Severini has also served on numerous local and national committees including the Manitoba Drug Standards and Therapeutics Committee, the Canadian Drug Expert Committee, the Association of Faculties of Pharmacy of Canada, the Pharmacy Examining Board of Canada, and the Women’s Health Research Foundation of Canada. Dr. Alessi-Severini received the Leslie F. Buggey Professorship in Pharmacy and the 2020 Ed Kroeger Mentorship Award. She has been a member of the Manitoba team of CNODES since its inception.
CNODES Projects
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Collaborator, ManitobaAtypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Site Investigator, ManitobaSodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Site Investigator, ManitobaSodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study
Site Investigator, ManitobaSodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
Site Investigator, ManitobaSodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
Site Investigator, ManitobaCharacteristics of new users of newer antidiabetic drugs in Canada and the United Kingdom
Site Investigator, ManitobaValidity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study
Collaborator, Manitoba- Site Investigator, Manitoba
Utilization Analysis of Tofacitinib and Other Drugs Among Individuals with Ulcerative Colitis: Feasibility Analysis
Site Investigator, Manitoba